IOL Chemicals and Pharmaceuticals Share Price

IOL Chemicals and Pharmaceuticals Share Price

NSE: IOLCP
|
Pharmaceuticals
|
S Cap
₹ 166.02
+₹7.60 (4.80%)
1D
Last updated 13 Aug, 2026, 15:55 IST

IOL Chemicals and Pharmaceuticals Share Price Today

As of 14 Aug 2026, IOL Chemicals and Pharmaceuticals share price is ₹166.02. The stock opened at ₹159.90, compared to its previous close of ₹158.42. During today's trading session, IOL Chemicals and Pharmaceuticals share price moved in the range of ₹159.23 to ₹169.50, with an average price of ₹164.37 for the day. Looking at its last 52-week, the stock has touched a low of ₹67.19 and a high of ₹179.60. On the performance front, IOL Chemicals and Pharmaceuticals share price has increased by 122.13% over the last six months and is up 78.08% on a year-on-year basis.

₹159.23
4.80% up today
₹169.50
1D LOW
1D HIGH

IOL Chemicals and Pharmaceuticals Returns Calculator

Circuit
L
H
₹132.82
₹199.22
52-week
L
H
₹67.19
₹179.60

About IOL Chemicals and Pharmaceuticals

IOL Chemicals and Pharmaceuticals Share Price
ISIN
INE485C01029
Sector Market Cap
₹ 4,645.07 Cr

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.

IOL Chemicals and Pharmaceuticals Financial Highlights

  • Revenue: IOL Chemicals and Pharmaceuticals reported revenue of ₹2,340.44 crore in FY26 vs ₹2,101.62 crore in FY25. It showed an increase of 11.36% on a yearly basis.
  • Operating Profit: IOL Chemicals and Pharmaceuticals reported an operating profit of ₹184.36 crore in FY26 vs ₹137.96 crore in FY25. It showed an increase of 33.63% on a year-on-year basis.
  • Net Profit: IOL Chemicals and Pharmaceuticals reported a net profit of ₹137.64 crore in FY26 vs ₹101.07 crore in FY25. It showed an increase of 36.18% on a yearly basis.

IOL Chemicals and Pharmaceuticals Quarterly Result Highlights

  • IOL Chemicals and Pharmaceuticals reported revenue of ₹621.29 crore in Mar 2026, compared with ₹585.68 crore in Dec 2025, representing an increase of 6.08% on a quarter-on-quarter (QoQ) basis.
  • IOL Chemicals and Pharmaceuticals reported an operating profit of ₹70.81 crore in Mar 2026, compared with ₹27.55 crore in Dec 2025, representing an increase of 157.02% on a quarter-on-quarter (QoQ) basis.
  • IOL Chemicals and Pharmaceuticals reported a profit of ₹53.16 crore in Mar 2026, compared with ₹20.58 crore in Dec 2025, reflecting an increase of 158.31% on a QoQ basis.
  • The earnings per share (EPS) of IOL Chemicals and Pharmaceuticals stood at ₹4.69 during Mar 2026.
Know more
Promoters
62.28%
FII
4.87%
Other DII
0.41%
Retail and other
32.42%
Mutual funds
0.02%
Foreign institutions - FII
FII shareholding by period
Sep 20252.25%
Dec 20252.08%
Mar 20261.72%
Jun 20264.87%
Mkt Cap Cr
4,645.07
P/E
27.62
P/B
2.58
ROE
7.65%
D/E
0.08
ROCE
10.29%
Div. Yield
0.63%
EPS(TTM)
4.69
Turnover
0.98
EV/EBITDA
14.80
Net Margin
5.94%
Op. Margin
12.04%
ROA
6.50%
Quick Ratio
1.24
Curr. Ratio
2.20
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
IOL Chemicals has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
IOL Chemicals appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
IOL Chemicals revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,64,271.0038.325.5613.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.5513.5315.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,20,099.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.183.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.624.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,662.0031.622.6411.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,700.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

IOL Chemicals and Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,319.06₹2,079.21₹2,132.79₹2,217.11
Other Income₹21.38₹22.41₹30.07₹25.61
Total Revenue₹2,340.44₹2,101.62₹2,162.86₹2,242.72
Total Expenses₹2,144.87₹1,963.66₹1,981.21₹2,054.07
Profit Before Tax₹184.36₹137.96₹181.65₹188.65
Tax₹46.72₹36.89₹47.22₹49.51
Profit After Tax₹137.64₹101.07₹134.43₹139.14
EPS - Basic₹4.69₹3.44₹4.58₹23.70
EPS - Diluted₹4.69₹3.44₹4.58₹23.70

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹184.36₹137.96₹181.65₹188.65
Income before WC changes₹269.40₹217.81₹241.47₹233.06
Change in Assets-₹83.91₹25.18-₹71.66₹41.30
Change in Liabilities₹66.69-₹46.05₹161.99-₹104.99
Change in WC-₹17.22-₹20.87₹90.33-₹63.69
Cash flow from Operations₹214.32₹178.62₹289.78₹122.27
Cash flow from Investing-₹198.11-₹154.18-₹190.98-₹120.00
Cash flow from Financing-₹29.03₹46.04-₹92.50-₹4.11
Total Cash Flow-₹12.82₹70.48₹6.30-₹1.84
Cash (Start of the year)₹78.17₹7.69₹1.39₹3.23
Cash (End of the year)₹65.35₹78.17₹7.69₹1.39

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,359.32₹1,230.73₹1,124.63₹1,101.74
Current Assets₹1,227.63₹1,151.34₹1,119.77₹920.39
Total Assets₹2,586.95₹2,382.07₹2,244.40₹2,022.13
Current Liabilities₹690.18₹609.91₹560.00₹456.26
Net Current Asset₹537.45₹541.43₹559.77₹464.13
Non-Current Liabilities₹98.22₹84.50₹72.89₹58.15
Equity Capital₹1,798.55₹1,687.66₹1,611.51₹1,507.72
Total Equity & Liabilities₹2,586.95₹2,382.07₹2,244.40₹2,022.13

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,079.21₹2,132.79₹2,217.11₹2,184.02
Other Income₹22.40₹30.07₹25.57₹32.04
Total Revenue₹2,101.61₹2,162.86₹2,242.68₹2,216.06
Total Expenses₹1,963.72₹1,980.22₹2,053.19₹1,979.29
Profit Before Tax₹137.89₹182.64₹189.49₹222.84
Tax₹36.89₹47.22₹49.51₹57.18
Profit After Tax₹101.00₹135.42₹139.98₹165.66
EPS - Basic₹3.44₹4.61₹23.84₹28.22
EPS - Diluted₹3.44₹4.61₹23.84₹28.22

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹184.44₹137.89₹182.64₹189.49
Income before WC changes₹269.52₹217.67₹242.40₹233.91
Change in Assets-₹83.79₹25.18-₹71.90₹41.67
Change in Liabilities₹66.55-₹45.85₹161.98-₹105.34
Change in WC-₹17.24-₹20.67₹90.08-₹63.67
Cash flow from Operations₹214.42₹178.68₹290.46₹123.14
Cash flow from Investing-₹198.12-₹154.23-₹191.39-₹119.19
Cash flow from Financing-₹29.03₹46.04-₹92.50-₹4.11
Total Cash Flow-₹12.73₹70.49₹6.57-₹0.16
Cash (Start of the year)₹78.02₹7.53₹0.96₹1.12
Cash (End of the year)₹65.29₹78.02₹7.53₹0.96

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,230.66₹1,124.49₹1,101.54₹881.58
Current Assets₹1,151.12₹1,119.48₹919.07₹1,078.71
Total Assets₹2,381.78₹2,243.97₹2,020.61₹1,960.29
Current Liabilities₹609.87₹559.75₹455.91₹513.40
Net Current Asset₹541.25₹559.73₹463.16₹565.31
Non-Current Liabilities₹84.50₹72.89₹58.15₹56.62
Equity Capital₹1,687.41₹1,611.33₹1,506.55₹1,390.27
Total Equity & Liabilities₹2,381.78₹2,243.97₹2,020.61₹1,960.29
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
166.02
34
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 34
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
54.32
Neutral
ATR (14)
7.65
Neutral
STOCH(9,6)
42.2
Neutral
STOCH RSI (14)
42.37
Neutral
ADX(9)
23.42
Bearish
UO(9)
48.59
Neutral
ROC(12)
4.6
Bullish
WillR(14)
-57.8
Neutral
Period
Simple value
Exponential vaue
5D
163.65
161.37
10D
157.81
159.3
20D
154.37
156.3
50D
147.23
145.51
100D
121.3
128.86
Volume trend — traded volume by day
13 Aug31L
12 Aug20L
11 Aug44L
10 Aug1Cr
7 Aug45L
Average58L
Compare against other stocks
IOL Chemicals and Pharmaceuticals Share Price
IOL Chemicals and Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

IOL Chemicals and Pharmaceuticals Share Price FAQs